Evrofarma SA

Athens Stock Exchange EVROF.AT

Evrofarma SA Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -2.10 M

Evrofarma SA Net Cash Used Provided By Financing Activities is USD -2.10 M for the year ending December 31, 2023, a -1,563.67% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Evrofarma SA Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -126.25 K, a -109.14% change year over year.
Evrofarma SA Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 1.38 M, a -51.92% change year over year.
Evrofarma SA Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 2.87 M, a 286.93% change year over year.
Evrofarma SA Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD -1.54 M, a 14.72% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Athens Stock Exchange: EVROF.AT

Evrofarma SA

CEO	Mr. Paschalis H. Papazilakis
IPO Date	June 13, 2000
Location	Greece
Headquarters	1st km Didymoteicho – Orestiada
Employees	166
Sector	Consumers Staples
Industries Dairy & Milk

Description

Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, cheese, and fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.

Key trends

Past 5 years